• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病例报告:一例费城染色体阳性的T细胞淋巴母细胞淋巴瘤病例及文献综述

Case Report: A Case With Philadelphia Chromosome Positive T-Cell Lymphoblastic Lymphoma and a Review of Literature.

作者信息

Li Xuewei, Ping Nana, Wang Yong, Xu Xiaoyu, Gao Lijuan, Zeng Zhao, Zhang Ling, Zhang Zhibo, Xie Yiyu, Ruan Changgeng, Wu Depei, Jin Zhengming, Chen Suning

机构信息

Department of Hematology, First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Suzhou, China.

Department of Thrombosis and Hemostasis, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Suzhou, China.

出版信息

Front Oncol. 2021 Jan 20;10:584149. doi: 10.3389/fonc.2020.584149. eCollection 2020.

DOI:10.3389/fonc.2020.584149
PMID:33552960
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7857119/
Abstract

Philadelphia chromosome positive (Ph) in T-lineage acute lymphoproliferative tumors is a rare event in both children and adults. In particular, it has not been reported in T-cell lymphoblastic lymphoma(T-LBL) yet. Here, we describe a patient with Ph T-LBL for both cytogenetic abnormality and fusion transcript. Moreover, we review the published cases of Ph T-cell acute lymphoblastic leukemia (T-ALL) in the literature and summarize their clinical characteristics, management, and prognosis.

摘要

费城染色体阳性(Ph)在T系急性淋巴细胞增殖性肿瘤中,无论在儿童还是成人中都是罕见事件。特别是,T细胞淋巴母细胞淋巴瘤(T-LBL)中尚未有相关报道。在此,我们描述了一名患有Ph T-LBL的患者,其存在细胞遗传学异常和融合转录本。此外,我们回顾了文献中已发表的Ph T细胞急性淋巴细胞白血病(T-ALL)病例,并总结了它们的临床特征、治疗及预后情况。

相似文献

1
Case Report: A Case With Philadelphia Chromosome Positive T-Cell Lymphoblastic Lymphoma and a Review of Literature.病例报告:一例费城染色体阳性的T细胞淋巴母细胞淋巴瘤病例及文献综述
Front Oncol. 2021 Jan 20;10:584149. doi: 10.3389/fonc.2020.584149. eCollection 2020.
2
P190 in a Patient with Philadelphia Chromosome Positive T-Cell Acute Lymphoblastic Leukemia: A Rare Case Report and Review of Literature.费城染色体阳性T细胞急性淋巴细胞白血病患者中的P190:一例罕见病例报告及文献复习
Case Rep Oncol. 2021 Jul 1;14(2):1040-1050. doi: 10.1159/000516270. eCollection 2021 May-Aug.
3
A rare case of Philadelphia-positive (P210BCR-ABL1) T-cell acute lymphoblastic leukemia/lymphoma associated with minimal residual disease persistence after intensive chemotherapeutic approaches.1例罕见的费城染色体阳性(P210 BCR-ABL1)T细胞急性淋巴细胞白血病/淋巴瘤,强化化疗后仍存在微小残留病。
Leuk Res Rep. 2024 Mar 24;21:100456. doi: 10.1016/j.lrr.2024.100456. eCollection 2024.
4
Adult acute lymphoblastic leukemia with a rare b3a3 type BCR/ABL1 fusion transcript.伴有罕见b3a3型BCR/ABL1融合转录本的成人急性淋巴细胞白血病。
Cancer Genet. 2016 Apr;209(4):161-5. doi: 10.1016/j.cancergen.2015.12.014. Epub 2016 Jan 11.
5
Philadelphia chromosome positive pre-T cell acute lymphoblastic leukemia: a rare case report and short review.费城染色体阳性前体T细胞急性淋巴细胞白血病:一例罕见病例报告及简要综述
Indian J Hematol Blood Transfus. 2014 Sep;30(Suppl 1):177-9. doi: 10.1007/s12288-013-0314-8. Epub 2014 Jan 22.
6
Association of cytogenetic abnormalities with detection of BCR-ABL fusion transcripts in children with T-lineage lymphoproliferative diseases (T-ALL and T-NHL).
Pediatr Blood Cancer. 2004 Mar;42(3):278-80. doi: 10.1002/pbc.10453.
7
Molecular Monitoring in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with the Variant e13a3 Fusion.成人费城染色体阳性急性淋巴细胞白血病伴e13a3变异融合的分子监测
Case Rep Hematol. 2019 Jun 27;2019:9635070. doi: 10.1155/2019/9635070. eCollection 2019.
8
Philadelphia chromosome-positive lymphoblastic lymphoma-Is it rare or underdiagnosed?费城染色体阳性淋巴细胞淋巴瘤——它是罕见还是诊断不足?
Hematol Oncol Stem Cell Ther. 2020 Dec;13(4):242-243. doi: 10.1016/j.hemonc.2018.05.007. Epub 2018 Jun 15.
9
Clinical implications of cytogenetic heterogeneity in Philadelphia chromosome positive (Ph+) adult B cell acute lymphoblastic leukemia following tyrosine kinase inhibitors and chemotherapy regimens.费城染色体阳性(Ph+)成人 B 细胞急性淋巴细胞白血病在酪氨酸激酶抑制剂和化疗方案治疗后的细胞遗传学异质性的临床意义。
Leuk Res. 2019 Sep;84:106176. doi: 10.1016/j.leukres.2019.106176. Epub 2019 Jun 27.
10
A rare BCR-ABL1 transcript in Philadelphia-positive acute myeloid leukemia: case report and literature review.费城阳性急性髓系白血病中一种罕见的 BCR-ABL1 转录本:病例报告及文献复习。
BMC Cancer. 2019 Jan 10;19(1):50. doi: 10.1186/s12885-019-5265-5.

引用本文的文献

1
A rare case of Philadelphia-positive (P210BCR-ABL1) T-cell acute lymphoblastic leukemia/lymphoma associated with minimal residual disease persistence after intensive chemotherapeutic approaches.1例罕见的费城染色体阳性(P210 BCR-ABL1)T细胞急性淋巴细胞白血病/淋巴瘤,强化化疗后仍存在微小残留病。
Leuk Res Rep. 2024 Mar 24;21:100456. doi: 10.1016/j.lrr.2024.100456. eCollection 2024.
2
Philadelphia chromosome-positive T-cell acute lymphoblastic leukemia: a case report.费城染色体阳性 T 细胞急性淋巴细胞白血病:一例报告。
J Int Med Res. 2024 Feb;52(2):3000605231156757. doi: 10.1177/03000605231156757.
3
BRCA2 germline mutation in familial leukaemia with familial breast cancer: a case report.

本文引用的文献

1
Philadelphia Chromosome-Positive T-cell Acute Lymphoblastic Leukemia: A Case Report and Review of the Literature.费城染色体阳性T细胞急性淋巴细胞白血病:一例报告并文献复习
Hematol Oncol Stem Cell Ther. 2022 Mar 1;15(1):59-62. doi: 10.1016/j.hemonc.2020.02.004.
2
Evidence for BCR/ABL1-positive T-cell acute lymphoblastic leukemia arising in an early lymphoid progenitor cell.证据表明,BCR/ABL1 阳性 T 细胞急性淋巴细胞白血病起源于早期淋巴祖细胞。
Pediatr Blood Cancer. 2019 Sep;66(9):e27829. doi: 10.1002/pbc.27829. Epub 2019 May 28.
3
Minimal residual disease in adult ALL: technical aspects and implications for correct clinical interpretation.
伴有家族性乳腺癌的家族性白血病中的BRCA2种系突变:一例报告
Ann Hematol. 2024 Feb;103(2):685-687. doi: 10.1007/s00277-023-05546-2. Epub 2023 Nov 20.
4
Detection of translocation using dual color FISH probes in T-cell acute lymphoblastic leukemia-an illustrative report and review of literature.使用双色荧光原位杂交探针检测T细胞急性淋巴细胞白血病中的易位——一份实例报告及文献综述
Blood Res. 2022 Dec 31;57(4):278-281. doi: 10.5045/br.2022.2022134. Epub 2022 Nov 9.
5
A Case of -positive T-lymphoblastic Leukemia With a Minor Philadelphia-positive Clone.一例伴有微小费城染色体阳性克隆的阳性T淋巴细胞白血病病例。
Ann Lab Med. 2023 Jan 1;43(1):100-103. doi: 10.3343/alm.2023.43.1.100. Epub 2022 Sep 1.
6
P190 in a Patient with Philadelphia Chromosome Positive T-Cell Acute Lymphoblastic Leukemia: A Rare Case Report and Review of Literature.费城染色体阳性T细胞急性淋巴细胞白血病患者中的P190:一例罕见病例报告及文献复习
Case Rep Oncol. 2021 Jul 1;14(2):1040-1050. doi: 10.1159/000516270. eCollection 2021 May-Aug.
成人急性淋巴细胞白血病中的微小残留病:技术层面及其对正确临床解读的意义
Blood Adv. 2017 Nov 28;1(25):2456-2466. doi: 10.1182/bloodadvances.2017009845.
4
Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies.基于免疫球蛋白/T 细胞受体和 BCR/ABL1 方法学,伊马替尼治疗后基于微小残留病灶预测费城染色体阳性急性淋巴细胞白血病的欧洲研究组的诱导治疗后治疗的费城染色体阳性急性淋巴细胞白血病的预测价值。
Haematologica. 2018 Jan;103(1):107-115. doi: 10.3324/haematol.2017.176917. Epub 2017 Oct 27.
5
Clinical characteristics of Philadelphia positive T-cell lymphoid leukemias-(De novo and blast phase CML).费城染色体阳性T细胞淋巴白血病的临床特征 - (初发及急变期慢性粒细胞白血病)
Am J Hematol. 2017 Jan;92(1):E3-E4. doi: 10.1002/ajh.24579. Epub 2016 Nov 18.
6
A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: final results of the GIMEMA LAL 0904 study.成人Ph+急性淋巴细胞白血病采用伊马替尼、化疗和移植的序贯治疗方法:GIMEMA LAL 0904研究的最终结果
Haematologica. 2016 Dec;101(12):1544-1552. doi: 10.3324/haematol.2016.144535. Epub 2016 Aug 11.
7
Lymphoblastic lymphoma: an updated review on biology, diagnosis, and treatment.淋巴母细胞淋巴瘤:生物学、诊断及治疗的最新综述
Eur J Haematol. 2016 May;96(5):447-60. doi: 10.1111/ejh.12722. Epub 2016 Jan 24.
8
Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.一项关于化疗联合达沙替尼用于初治费城染色体阳性急性淋巴细胞白血病患者的2期研究的长期随访
Cancer. 2015 Dec 1;121(23):4158-64. doi: 10.1002/cncr.29646. Epub 2015 Aug 26.
9
IgH-V(D)J NGS-MRD measurement pre- and early post-allotransplant defines very low- and very high-risk ALL patients.异基因移植前及移植后早期的免疫球蛋白重链可变区(IgH)-V(D)J下一代测序微小残留病(NGS-MRD)检测可明确极低风险和极高风险的急性淋巴细胞白血病(ALL)患者。
Blood. 2015 May 28;125(22):3501-8. doi: 10.1182/blood-2014-12-615757. Epub 2015 Apr 10.
10
Final report of a phase II study of imatinib mesylate with hyper-CVAD for the front-line treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.甲磺酸伊马替尼联合hyper-CVAD一线治疗成人费城染色体阳性急性淋巴细胞白血病的II期研究最终报告
Haematologica. 2015 May;100(5):653-61. doi: 10.3324/haematol.2014.118588. Epub 2015 Feb 14.